SEC Form 5 · accession 0001179110-15-002629
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy M Mayleben
Officer — President & CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 3, 2013 | G | 4,500 | $0.00 | D | 24,314 | D | |
| Common Stock | Dec 22, 2014 | G | 500 | $0.00 | D | 23,814 | D |
Table II — derivative securities
No Table II lines on this filing.